Misoprostol use during the third stage of labor

被引:27
|
作者
Joy, SD [1 ]
Sanchez-Ramos, L [1 ]
Kaunitz, AM [1 ]
机构
[1] Univ Florida, Hlth Sci Ctr, Dept Obstet & Gynecol, Jacksonville, FL 32209 USA
关键词
misoprostol; postpartum hemorrhage; third stage of labor; meta-analysis;
D O I
10.1016/S0020-7292(03)00146-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To systematically review the efficacy of misoprostol compared with placebo or other uterotonics in preventing maternal morbidity associated with the third stage of labor. Methods: We identified, retrieved, evaluated, abstracted data, and assessed the quality of all published studies (from January 1996 to May 2002) which assessed misoprostol's efficacy in minimizing uterine blood loss during the third stage of labor. Seventeen studies included 28 170 subjects; of these, approximately one-half received misoprostol with the remainder receiving either a placebo or another uterotonic agent. An estimate of the odds ratio (OR) and risk difference for dichotomous outcomes was calculated using a random- and fixed-effects model. Continuous outcomes were pooled using a variance-weighted average of within-study difference in means. Results: In assessing studies comparing misoprostol with placebo, those who received oral misoprostol had a decreased risk of needing additional uterotonics (OR 0.64, 95% confidence interval 0.46, 0.90). Compared with placebo, use of misoprostol was associated with an increased risk for shivering and pyrexia. In contrast, in studies comparing misoprostol with oxytocin, oxytocin was associated with significantly lower rates of postpartum hemorrhage, maternal shivering and pyrexia. In studies comparing misoprostol with Syntometrine, misoprostol was associated with higher rates of the need for additional uterotonic agent as well as shivering. Conclusions: Misoprostol was inferior to oxytocin and other uterotonics with regard to any of the third stage of labor outcomes assessed. However, when compared to placebo, misoprostol had a decreased risk of needing additional uterotonics. Thus, in less-developed countries where administration of parenteral uterotonic drugs may be problematic, misoprostol represents a reasonable agent for the management of the third stage of labor. Additional randomized clinical trials examining objective outcome measures (i.e. need for blood transfusion or 10% hemoglobin change) may further define benefits and risks of misoprostol use during the third stage of labor. (C) 2003 International Federation of Gynecology and Obstetrics. Published by Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 50 条
  • [21] Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor
    Khan, RU
    El-Refaey, H
    OBSTETRICS AND GYNECOLOGY, 2003, 101 (05): : 968 - 974
  • [22] Use of oxytocin during early stages of labor and its effect on active management of third stage of labor
    Sosa, Claudio G.
    Althabe, Fernando
    Belizan, Jose M.
    Buekens, Pierre
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (03)
  • [23] The use of oxytocin administration to manage the third stage of labor
    Shojai, R
    d'Ercole, C
    Boubli, L
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 187 (02) : 516 - 517
  • [24] Rectal versus oral misoprostol for active management of third stage of labor: a randomized controlled trial
    Mansouri, H. A.
    Alsahly, N.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (05) : 935 - 939
  • [25] A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor
    Lam, H
    Tang, OS
    Lee, CP
    Ho, PC
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2004, 83 (07) : 647 - 650
  • [26] Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor
    Singh, Gunjan
    Radhakrishnan, Gita
    Guleria, Kiran
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 107 (02) : 130 - 134
  • [27] Low-dose sublingual misoprostol versus methylergometrine for active management of the third stage of labor
    Chhabra, Shakuntala
    Tickoo, Chandan
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2008, 34 (05) : 820 - 823
  • [28] A Comparative Study of Sublingual Misoprostol Versus Intramuscular Oxytocin in the Active Management of Third Stage of Labor
    Mishra, Shweta
    Tirkey, Sarita
    Prasad, Anupa
    Trivedi, Kiran
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [29] Rectal versus oral misoprostol for active management of third stage of labor: a randomized controlled trial
    H. A. Mansouri
    N. Alsahly
    Archives of Gynecology and Obstetrics, 2011, 283 : 935 - 939
  • [30] Sonographic and clinical findings during the third stage of labor
    Krapp, M
    Baschat, AA
    Hankeln, M
    Geipel, A
    Germer, U
    Gembruch, U
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2001, 61 (07) : 507 - 510